European STD diagnostics market is growing at a CAGR of around 8.4% during the forecast period. As per MedTech Europe, in 2017, there were more than 27,000 medical technology companies in Europe out of which 95% were SMEs. Most of the companies are based in Germany, UK, Italy, Switzerland, Spain, and France. In Europe, around 10% of the GDP is spent on healthcare, out of which around 6.5% is dedicated to medical devices, that value is less than 1% of the GDP. Per capita expenditure on the medical device was around $220 in 2017 which directly affects the growth of the European STD diagnostics market during the forecast period.
Free Sample Copy @ https://www.omrglobal.com/request-sample/european-sexually-transmitted-disease-market
The medical device market in Europe is growing with an average of 4.3% per annum over the past decade. Demand was very low in 2009 and 2011 which recovered significantly in a couple of years in the region. Europe is the major trader of medical devices with the US. 40.7% of the total exports were to the US whereas around 52.6% of the total medical device import was from the US. Europe had a positive medical device trade balance of nearly $22.4 billion in 2017. Thus, the growth in the overall devices market will influence the growth of the European STD diagnostics market.
A Full Report of European Sexually Transmitted Diseases (STD) Diagnostics Market is Available at:
https://www.omrglobal.com/industry-reports/european-sexually-transmitted-disease-market
The companies which are contributing significantly in the European STD diagnostics market include Abbott Laboratories, Becton, Dickinson and Co., Biocartis NV, Bio-Rad Laboratories, Inc., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd. among others. The players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
European Sexually Transmitted Diseases (STD) Diagnostics Market – Segmentation
by Disease Type
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus (HSV)
Human Papilloma Virus (HPV)
Human Immunodeficiency Virus (HIV)
Others
by Product
Laboratory Testing Devices
Point-of-Care (POC) Testing Devices
by End-user
Hospitals and Clinics
Diagnostic Centers
Homecare
European Sexually Transmitted Diseases (STD) Diagnostics Market – Segmentation by Region
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Company Profiles
Abbott Laboratories, Inc.
AbbVie Inc.
Becton, Dickinson and Co.
Biocartis NV
Bio-Rad Laboratories, Inc.
Danaher Corp.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck KGaA
Thermo Fisher Scientific, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-sexually-transmitted-disease-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
(This release has been published on Global Market Post.
Global Market Post is not responsible for any content included in this release.)
